Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Methemoglobinemia

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Methemoglobinemia in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duflou, J1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Methemoglobinemia

ArticleYear
A case of fatal 2,4-dinitrophenol (2,4-DNP) intoxication with delayed onset methaemoglobinaemia.
    Pathology, 2019, Volume: 51, Issue:5

    Topics: 2,4-Dinitrophenol; Alcohol Drinking; Autopsy; Fatal Outcome; Humans; Male; Methemoglobinemia; N-Meth

2019